Page last updated: 2024-11-05

trimethoprim and Bowel Diseases, Inflammatory

trimethoprim has been researched along with Bowel Diseases, Inflammatory in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research Excerpts

ExcerptRelevanceReference
" Results showed no adverse effects in the oral toxicity tests."1.40Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing. ( Boyen, F; Deforce, D; Ducatelle, R; Eeckhaut, V; Haesebrouck, F; Steppe, M; Van Immerseel, F; Van Nieuwerburgh, F; Vercauteren, G, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steppe, M1
Van Nieuwerburgh, F1
Vercauteren, G1
Boyen, F1
Eeckhaut, V1
Deforce, D1
Haesebrouck, F1
Ducatelle, R1
Van Immerseel, F1

Other Studies

1 other study available for trimethoprim and Bowel Diseases, Inflammatory

ArticleYear
Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3(T), a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 72

    Topics: Aminoglycosides; Animals; Anti-Infective Agents; Butyrates; Consumer Product Safety; DNA, Bacterial;

2014